Key facts
- This page summarizes Bruce S. Johnson's Form 4 filing for GLYCOMIMETICS INC (GLYC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 May 2023, 17:00.
Bruce S. Johnson - 08 May 2023 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)
- Reporting relationship
- SVP & Chief Commercial Officer
- Issuer ticker
- GLYC
- Reported as of
- 08 May 2023
- Net transaction value
- +$21,195
- SEC form
- 4
- Accepted by SEC
- 09 May 2023, 17:00:19 UTC
- Prior SEC filing
- 31 Mar 2023
- Next SEC filing
- 17 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian F. Leaf, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Bruce S. Johnson filed Form 4 for GLYCOMIMETICS INC (GLYC) on 09 May 2023.
Change
- Previous filing in this sequence was filed on 31 Mar 2023.
- Current net transaction value: +$21,195.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GLYC
transaction
Common Stock
Purchase
- Transaction value
- $21,195
- Shares
- +13,500
- Change %
- +11%
- Price
- $1.57
- Shares after
- 138,980
- Date
- 08 May 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.